Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Grieb

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Medicine|April 22, 2008
Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signalingJiahua Jiang, Brian Grieb, Anita Thyagarajan, et al.
Journal of Palliative Medicine|February 14, 2017
The View from My SeatAshley Karpinos, Brian Grieb, Liza Weavind, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
5-Azacytidine incorporation into mRNAs disrupts translation and induces ribosome collisionsAlexis B Roberson, James Marks, Ruby Pitts, et al.
NPJ Precision Oncology|June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligenceSebastian Cole, Paul Campitelli, Brian Grieb, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Medicine|April 22, 2008
Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signalingJiahua Jiang, Brian Grieb, Anita Thyagarajan, et al.
Journal of Palliative Medicine|February 14, 2017
The View from My SeatAshley Karpinos, Brian Grieb, Liza Weavind, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
5-Azacytidine incorporation into mRNAs disrupts translation and induces ribosome collisionsAlexis B Roberson, James Marks, Ruby Pitts, et al.
NPJ Precision Oncology|June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligenceSebastian Cole, Paul Campitelli, Brian Grieb, et al.
Pageof 1